Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
HeartSciences Inc. incurred loan of up to $1,000,000 with Matthews Southwest Holdings, Inc. at no interest, except upon an event of default, at which time, interest accrues at maturing December 31, 2023.
- Instrument
- loan
- Principal
- up to $1,000,000
- Counterparty
- Matthews Southwest Holdings, Inc.
- Rate
- no interest, except upon an event of default, at which time, interest accrues at
- Maturity
- December 31, 2023
- Event
- incurrence
Exact text from the filing
Unsecured Promissory Drawdown Loan Note (the "MSW Note") with Matthews Southwest Holdings, Inc. (the "Lender"). The MSW Note provides for an unsecured drawdown loan of up to $1,000,000, drawn in installments consisting of (i) $250,000 on or prior to September 8, 2023, (ii) $250,000 on or prior to September 20, 2023, and (iii) further drawdowns of up to $500,000
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
HeartSciences Inc. entered into Senior Unsecured Promissory Drawdown Loan Note with Matthews Southwest Holdings, Inc. valued at up to $1,000,000 unsecured drawdown loan, issued in installments: $250,000 on or prior to September (effective 2023-09-07).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Matthews Southwest Holdings, Inc.
- Value
- up to $1,000,000 unsecured drawdown loan, issued in installments: $250,000 on or prior to September
- Effective
- 2023-09-07
Exact text from the filing
On September 7, 2023, Heart Test Laboratories, Inc. (the "Company") entered into a Senior Unsecured Promissory Drawdown Loan Note (the "MSW Note") with Matthews Southwest Holdings, Inc. (the "Lender").
View on SEC.gov